破骨细胞
细胞生物学
KEAP1型
化学
活性氧
基因敲除
调节器
氧化磷酸化
癌症研究
下调和上调
自噬
骨细胞
成骨细胞
磷酸化
骨吸收
氧化应激
线粒体
基因沉默
骨重建
兰克尔
脱磷
骨质疏松症
秩配基
激酶
基因表达调控
线粒体ROS
信号转导
蛋白酶体
生物
作者
Xiaojun Chen,Chengyu Zhou,Xiangyun Jin,Qiongxiang Lin,Lizhen Li,Zhongxiang Wang,Buran Chen,Qiu Dong,Jianbo He,Kavishadhi N. Chandrasekaran,Chau Bui,Alysia Hubbard,Qunwei Dong,Lei Chen,K. Swaminathan Iyer,Jiandong Yuan,Nathan John Pavlos,Haibo Jiang,Kai Chen
标识
DOI:10.1038/s41467-026-77379-2
摘要
Osteoclasts are mitochondria-rich cells that rely on oxidative phosphorylation to fuel differentiation and bone resorption. Oxidative phosphorylation generates reactive oxygen species (ROS), which support signaling but can also threaten mitochondrial integrity. Oxidation Resistance 1 (OXR1) is a redox-responsive regulator involved in antioxidant defense, but its role in osteoclasts remains unclear. Here, we show that OXR1 is upregulated during mouse osteoclastogenesis and OXR1 mRNA is enriched in human osteoclasts. Knockdown of Oxr1 in mouse osteoclast precursors causes excessive ROS accumulation, mitochondrial damage, and impaired autophagic flux. Accordingly, myeloid-specific loss of Oxr1 results in defective osteoclast formation and increased bone mass in mice. Mechanistically, OXR1 binds the antioxidant response regulator KEAP1 and promotes KEAP1 association with the autophagy adaptor P62/SQSTM1, thereby supporting mitochondrial ubiquitination and mitophagic clearance. In an ovariectomy-induced osteoporosis mouse model, intraosseous AAV9-shRNA-mediated Oxr1 silencing or pharmacological OXR1 inhibition suppresses osteoclast activity and attenuates bone loss. Thus, our findings suggest OXR1 to be a dual-function regulator that buffers ROS and simultaneously orchestrates the autophagic clearance of damaged mitochondria during osteoclastogenesis, hinting at OXR1 as a potential target for preventing osteoclast‑driven bone loss. Osteoclasts need to manage reactive oxygen species by coordinating redox control and mitochondrial quality maintenance. Here, the authors identify OXR1 as a regulator of osteoclastogenesis and mitophagy, and show that genetic or pharmacological targeting of OXR1 attenuates bone loss in an osteoporosis mouse model.
科研通智能强力驱动
Strongly Powered by AbleSci AI